Study to Assess the Efficacy and Safety of NBI-1065845 in Adults With Major Depressive Disorder (MDD)
Summary
- Eligibility
- for people ages 18-65 (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Neurocrine Biosciences
- Links
- Study Website - Savitri Study
- ID
- NCT05203341
- Phase
- Phase 2 Depression Research Study
- Study Type
- Interventional
- Participants
- Expecting 155 study participants
- Last Updated